Last updated on April 2019

An Investigational Immuno-Therapy Study of Experimental Medication BMS-986253 Given in Combination With Nivolumab in Patients With Advanced Cancers

Brief description of study

The purpose of this study is to investigate experimental medication BMS-986253 in combination with Nivolumab in patients with advanced cancers.

Clinical Study Identifier: NCT03400332

Find a site near you

Start Over

Hospital Clinico Univ. de Santiago-CHUS

Santiago Compostela, Spain
  Connect »